510(k) Report

510(k) · Cleared

Cleared

gammaCore Sapphire

K182369510(k) TraditionalCleared Nov 27, 201888-day reviewClass II21 CFR 882.5892

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Electrocore, Inc. · PKR Non-Invasive Vagus Nerve Stimulator - Headache

Cleared on Nov 27, 2018 as substantially equivalent to K180538 (Electrocore, LLC, 2018) after an 88-day review. Its family tree reaches back 4 generations to 2017. 3 later devices descend from it.

Decided
Nov 27, 2018
Review
88 days
Class
Class II
Product code
PKR
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to DEN150048 (2017). 3 later devices descend from it, 1 citing it directly.

Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant K180538 · gammaCore Sapphire · Electrocore, LLC · 2018K172270 · gammaCore-2 · Eletrocore, LLC · 2017K171306 · gammaCore-S · Electrocore, LLC · 2017DEN150048 · gammaCore Non-invasive Vagus Nerve Stimulator · Electrocore, LLC · 20170
  1. Root · 4 generations backDEN150048 gammaCore Non-invasive Vagus Nerve StimulatorElectrocore, LLC · 2017
  2. 3 generations backK171306 gammaCore-SElectrocore, LLC · 2017
  3. 2 generations backK172270 gammaCore-2Eletrocore, LLC · 2017
  4. 1 generation backK180538 gammaCore SapphireElectrocore, LLC · 2018
  5. This deviceK182369 gammaCore SapphireElectrocore, Inc. · 2018
  6. Descendant · cites it directly · 2 of its ownK191830 gammaCore SapphireElectrocore, Inc. · 2020
  7. Descendant · 2 generations on · 1 of its ownK203546 gammaCore SapphireElectrocore, Inc. · 2021
  8. Descendant · 3 generations on · 0 of its ownK211856 gammaCore SapphireElectrocore, Inc. · 2021

Most influential descendants

Showing 3 of 3 · See all
  • K191830gammaCore SapphireElectrocore, Inc. · 2020 · cites it directly2descendants
  • K203546gammaCore SapphireElectrocore, Inc. · 2021 · 2 generations on1descendant
  • K211856gammaCore SapphireElectrocore, Inc. · 2021 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4DEN150048gammaCore Non-invasive Vagus Nerve StimulatorElectrocore, LLC2017—
−3K171306gammaCore-SElectrocore, LLC2017—
−2K172270gammaCore-2Eletrocore, LLC2017—
−1K180538gammaCore SapphireElectrocore, LLC2018—
0 (this device)K182369gammaCore SapphireElectrocore, Inc.2018—
+1K191830gammaCore SapphireElectrocore, Inc.2020—
+2K203546gammaCore SapphireElectrocore, Inc.2021—
+3K211856gammaCore SapphireElectrocore, Inc.2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202120
FIG. 1 — Lineage of K182369, 2017–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PKR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PKR device

  1. #1 K203546 gammaCore Sapphirescore 5.3 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K180538gammaCore Sapphire
Summary page 5
…al nerve stimulator for headache Classification Status: Class II Product Codes: PKR, QAK Primary Predicate Device: gammaCore Sapphire, K180538 Reference Device: gammaCore-S, K173442 Indication for Use: The gammaCore Sapphire Non-invasive Vagus Nerve Stimu…
Electrocore, LLC2018—
†K173442gammaCore-SElectrocore, LLC2018—

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K191830gammaCore SapphireElectrocore, Inc.20202

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 1 year and passes through 3 companies; a new generation was cleared every 6 months on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K191830 (Electrocore, Inc., 2020) has gone furthest, with 2 descendants of its own.

How does its category compare?

All PKR devices

PKR Non-Invasive Vagus Nerve Stimulator - Headache: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · PKR

2in 2021

2017: 32018: 32020: 12021: 2
2007high 3 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PKR

78in 2018

2018: 78 days median
2007high 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PKR

No recall names PKR since 2007.

Adverse event reports per year · PKR

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2025

MAUDE reports naming product code PKR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20173—00
201837801
20190—00
20201—00
20212—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

gammaCore Sapphire (non-invasive vagus nerve stimulator) is intended to provide non-invasive vagus nerve stimulation (nVNS) on the side of the neck. gammaCore is indicated for:

• Adjunctive use for the preventive treatment of cluster headache in adult patients.

• The acute treatment of pain associated with episodic cluster headache in adult patients.

• The acute treatment of pain associated with migraine headache in adult patients.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K182369: gammaCore Sapphire.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K182369

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026